Zenith Therapeutics
Claudio Thoma is an experienced biologist currently serving as the Director of Biology at Zenith Therapeutics since January 2025. Previously, Claudio held the same title at Ridgeline Discovery from April 2023 to December 2024 and at Novartis Institutes for BioMedical Research (NIBR) from August 2014 to April 2023, where responsibilities included Associate Director and Senior Principal Scientist roles in Chemical Biology & Therapeutics and Oncology. Earlier in the career, Claudio worked as a Senior Scientist at ETH Zurich and completed postdoctoral fellowships at Harvard Medical School and ETH Zurich. Claudio holds a Doctor of Sciences in Cell/Cellular and Molecular Biology with a focus on cancer research, as well as a Dipl. Natw. ETH in Biochemistry and Molecular Biology from ETH Zurich, and an Eidgenoessische Matura in Mathematics from Alte Kantonsschule Aarau.
This person is not in any teams
This person is not in any offices
Zenith Therapeutics
Zenith Therapeutics is redefining drug discovery through a new approach to protein degradation, making hard-to-drug targets of high therapeutic value accessible to drug discovery.